Data protection Impressum

Life sciences

Siegfried’s Evionnaz site currently employs 380 professionals and is in the process of constructing a new R&D building, which is set to double the company's development capacity and create around 40 new jobs.

Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry

4 December 2023

EPFL’s innovation is designed to significantly enhance clinical decision-making by providing access to specialized medical knowledge.

Meditron, EPFL’s new Large Language Model for medical knowledge

29 November 2023

Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction.

Western Switzerland medtech start-ups embark on human trials

29 November 2023

Scheduled for completion by the end of 2032, the Digisanté program is led by the Federal Office of Public Health (OFSP) and the Federal Statistical Office (OFS).

A program to promote the digital transformation of the healthcare system

27 November 2023

The inclusion of Aktiia’s technology in the GAPP study is a testament to its potential in reshaping blood pressure research.

Aktiia’s blood pressure monitoring technology advances global cardiovascular research

14 November 2023

Empa is one of the partners who established the new "Dynamic Imaging Center" (DIC) in Bern.

Opening of the Dynamic Imaging Center at sitem-insel in Bern

13 November 2023

From left to right: Christoph Ammann, Canton of Bern - Dr. med. h.c. Uwe E. Jocham, Insel Gruppe - Prof. Dr. Christian Leumann, University of Bern - Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

Bern’s journey to becoming a world-class medtech hub by 2030

9 November 2023

LAGOSTA specializes in the sustainable farming of the European spiny lobster, converting byproducts in unique highly valuable products and setting up a series of ecological programs.

Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution

2 November 2023

This strategic partnership will allow Fapon to research, develop, make, and sell PSP materials and test solutions using the chemiluminescence immunoassay (CLIA) in the Chinese market.

Abionic and Lascco partner with Fapon for sepsis diagnosis in China

2 November 2023

Novochizol technology quantitatively transforms single linear chitosan molecules into cross-linked, uniformly sized nanospheres.

EPFL and Novochizol to collaborate on designing more efficient immunotherapies

2 November 2023

1 … 14 15 16 17 18 19 20 21 22 … 44